Buy Ajanta Pharma; target of Rs 1605: Motilal Oswal News News / News 7 years ago 609 Views comments Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1605 in its research report dated October... Read more
News Gadkari warns bus makers to shift to green fuel, match European quality standards News / News - 7 years ago
News In UN speech, Donald Trump reinforces tough US stand against countries supporting terror News / News - 7 years ago
Comments